Individuals with CHIP have a higher risk of developing a myeloid neoplasm, but are also at higher risk of developing cardiovascular diseases, type 2 diabetes, or second cancer and have a higher all-cause mortality [105,107,111,119]. This evidence concerns the gene STUB1 and cardiovascular disorder.